Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



KV Pharmaceutical Shares Plunged: What You Need to Know

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of drug company KV Pharmaceutical (NYSE: KV-A  ) slipped as much as 19% on heavier-than-average volume.

So what: After a yo-yo performance during Friday's trading session that had KV's stock down as much as 14% before it recovered substantially, KV is back in the dumps. The stock may be the victim of a rash of bad headlines, most of which stem from the company's decision to jack up the price of Makena, a drug that helps prevent premature births, from $15 per dose to $1,500 per dose. In unrelated news, KV's former CEO was sentenced to 30 days in jail after pleading guilty to mislabeling drugs in 2008.

Now what: With regards to Makena, investors may claim that KV is simply doing what it's supposed to do in order to maximize its profits. That's capitalism after all, right? Unfortunately, that's a point that will fall on many deaf ears as outraged cries grow that KV is making huge profits on sick babies. Right or wrong, the perception of it is terrible for KV.

Want to keep up to date on KV Pharmaceuticals? Add it to your watchlist.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Fool contributor Matt Koppenheffer does not own shares of any of the companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter @KoppTheFool or on his RSS feed. The Fool's disclosure policy prefers dividends over a sharp stick in the eye.

Read/Post Comments (1) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 14, 2011, at 5:06 PM, mkmar wrote:

    We have only seen the beginning of the backlash of the price gouging on Makena. Hopefully KV will understand this and reconsider their pricing. This stock will eventually be worthless otherwise as the lawsuits from price gouging causing increased stillbirths put them out of business next year

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1457934, ~/Articles/ArticleHandler.aspx, 10/21/2016 10:57:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,069.66 -92.69 -0.51%
S&P 500 2,136.92 -4.42 -0.21%
NASD 5,242.30 0.47 0.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
KVPHQ.DL $0.00 Down +0.00 +0.00%
K V Pharmaceutical… CAPS Rating: **